BGI Group   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Beijing China (1999)

Organization Overview

First Clinical Trial
2016
NCT02959905
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

BGI, China | BGI-research | BGI-Shenzhen